Efficient liver-directed gene transfer by in situ generation of retroviral vector from adenoviral templates

In Vivo

Volumn 23, Issue 6, 2009, Pages 885-893

  Harris, Julian D ^a   Roberts, Michael L ^c   Perumal, Dhayaneethie ^b   Graham, Ian R ^a   Patterson, Steve ^b   Dickson, George ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c Regulon SA   (Greece)

Author keywords

Adenovirus; Gene therapy; Hybrid vector; Liver; Retrovirus

Indexed keywords

ADENOVIRUS VECTOR; GAG PROTEIN; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; NEOMYCIN; POL PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN 10A1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO GENE TRANSFER; LEIN GENE; LIVER CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PROVIRUS; STRUCTURAL GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS PARTICLE;

EID: 75149143911     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ledley FD, Grenett HE, McGinnis-Shelnutt M and WOO SL: Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells. Proc Natl Acad Sci USA 83: 409-413, 1986.
2. Ledley FD, Darlington GJ, Hahn T and Woo SL: Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc Natl Acad Sci USA 84: 5335-5339, 1987.
3. Wilson JM, Jefferson DM, Chowdhury JR, Novikoff PM, Johnston DE and Mulligan RC: Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci USA 85: 3014-3018, 1988.
4. McCormack JE, Edwards W, Sensintaffer J, Lillegren L, Kozloski M, Brumm D, Karavodin L, Jolly DJ and Greengard J: Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector. Mol Ther 3: 516-525, 2001.
5. Podevin G, Pichard V, Durand S, Aubert D, Heloury Y and Ferry N: In vivo retroviral gene transfer to the liver is cancelled by an immune response against the corrected cells. Can it be avoided? Pediatr Surg Int 18: 595-599, 2002.
6. Welsh RM, Cooper NR, Jenson FC and Oldstone MBA: Human serum lyses RNA tumor viruses. Nature 257: 612-614, 1975.
7. Aoki M, Morishita R, Higaki J, Moriguchi A, Hayashi S, Matsushita H, Kida I, Tornita N, Sawa Y, Kaneda Y and Ogihara T: Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the non-infarcted area, but not the myocardial infracted area. Gene Ther 4: 120-127, 1997.
8. Kerr WG: Genetic modification of the hematolymphoid compartment for therapeutic purposes. Hematol Oncol Clin North Am 12: 503-519, 1998.
9. Overturf K, Al-dhalimy M, Manning K, Ou CN, Finegold M and Grompe M: Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia type I. Hum Gene Ther 9: 295-304, 1998.
10. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH and Blease RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992.
11. Fassati A, Wells DJ, Walsh F and Dickson G: Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle. Hum Gene Ther 7: 595-602, 1996.
12. Feng M, Jackson WH, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G and Curiel DT: Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nature Biotech 15: 866-870, 1997.
13. Lin X: Construction of new retroviral producer cells from adenoviral and retroviral vectors. Gene Ther 5: 1251-1258, 1998.
14. Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M and Blaese RM: Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors. Biochem Biophys Res Commun 246: 912-919, 1998.
15. Caplen NJ, Higginbotham JN, Scheel JR, Vahanian N, Yoshida Y, Hamada H, Blaese RM and Ramsey WJ: Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther 6: 454-459, 1999.
16. Duisit G, Salvetti A, Moullier P and Cosset FL: Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum Gene Ther 10: 189-200, 1999.
17. Roberts ML, Athanosopoulos T, Pohlschmidt M, Duisit G, Cosset FL and Dickson G: Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates. Gene Ther 8: 1580-1586, 2001.
18. Roberts ML, Wells DJ, Graham IR, Fabb SA, Hill VJ, Duisit G, Yuasa K, Takeda S, Cosset FL and Dickson G: Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. Hum Mol Genet 11: 1719-1730, 2002.
19. Wilson CA, Farrell KB and Eiden MV: Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells. J Virol 68: 7697-7703, 1994
20. Harris JD, Graham IR, Schepelmann S, Stannard AK, Roberts ML, Hodges BL, Hill VJ, Amalfitano A, Hassall DG, Owen JS and Dickson G: Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1-, E3-, polymerase-] adenovirus vector expressing human apoE. Hum Mol Genet 11: 43-58, 2002.
21. Themis M, Forbes SJ, Chan L, Cooper RG, Etheridge CJ, Miller AD, Hodgson HJF and Coutelle C: Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors. Gene Ther 5: 1180-1186, 1998.
22. Forbes SJ, Themis M, Alison MR, Seiden C, Coutelle C and Hodgson HJF: Retroviral gene transfer to the liver in vivo during tri-iodothryonine- induced hyperplasia. Gene Ther 5: 552-555, 1998.
23. Cosset FL, Takeuchi Y, Battini JL, Weiss RA and Collins MKL: High-titre packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69: 7430-7436, 1995.
24. Ory DS, Neugeboren BA and Mulligan RC: A stable human-derived packaging cell line for production of high titre retrovirus/vesicular stomatitis virus G pseudotypes. Proc Nat Acad Sci USA 93: 11400-11406, 1996.
25. Murphy SJ, Chong H, Bell S, Diaz RM and Vile RG: Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum Gene Ther 13: 745-760, 2002.